Navigation Links
Genetic diagnosis can rule out a suspected Huntington's chorea patient
Date:5/5/2014

Huntington's disease is an autosomal-dominant inherited neurodegenerative disease with a distinct phenotype, but the pathogenesis is unclear. Although patients with a family history have more typical clinical symptoms, signs, and pathological changes, as well as an unambiguous clinical diagnosis, other diseases with dance-like movements, e.g., dentatorubral-pallidoluy-sian atrophy, spinocerebellar ataxia type 17, Huntington's disease-like-2, and neuroferritinopathy, are difficult to identify and distinguish from Huntington's disease. By mutation screening for CAG repeats in the Huntington's disease-associated candidate gene, IT15, using reverse transcription-polymerase chain reaction, T-A cloning, and sequencing, Dr. Mingxia Yu and coworkers from Zhongnan Hospital of Wuhan University in China provide a global analysis incorporating clinical symptoms, imaging examinations, and gene diagnosis, of Huntington's disease. Their findings, published in the Neural Regeneration Research (Vol. 9, No. 4, 2014), suggest that clinical diagnosis of Huntington's disease requires a combination of clinical symptoms, radiological changes, and genetic diagnosis.


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Small variations in genetic code can team up to have a bi
2. Prostate cancer and blood lipids share genetic links
3. Octillions of microbes in the seas: Ocean microbes show incredible genetic diversity
4. Higher calcium intake may reduce body fat, mitigating genetic risk for diabetes
5. Genetic disorder causing strokes and vascular inflammation in children has been discovered
6. Tsetse fly genetic code sequenced
7. Genetic legacy of rare dwarf trees is widespread
8. Autism Genome Project delivers genetic discovery
9. Genetic code of the deadly tsetse fly unraveled
10. Genetics risk, prenatal smoking may predict behavioral problems
11. Genetic study tackles mystery of slow plant domestications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic diagnosis can rule out a suspected Huntington's chorea patient
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... at St. Jude Children,s Research Hospital have identified inherited variations ... acute lymphoblastic leukemia (ALL), including a gene that may help ... complete search of the human genetic blueprint or genome to ... childhood cancer. Published in the August 16 advance online issue ...
... at the Keck School of Medicine of the University ... mechanism that may govern an individual,s risk of developing ... Public Library of Science (PLoS) Genetics journal, ... no genes are present (gene ,deserts,) at a chromosomal ...
... at WPTRC is as diverse as the agencies that fund ... and studying the ecosystems of the island and the region. ... urging his,faculty to find new sources of external funds, and ... funding agencies that are now supporting the WPTRC and its ...
Cached Biology News:Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 3UOG scientists successfully compete for research grants 2
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in the healthcare, life science ... US-based company Nano-C, their development and launch of promising ... photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... growing OPV sector. Novel derivatives: highly stable, ...
(Date:8/3/2015)... -- E-QURE Corp. (OTCQB: EQUR), a Delaware ... Therapy device ("BST Device"), a new and novel electrotherapy ... wounds, today announced that the Company has signed its ... in medical devices, for the marketing and distribution of ... years old, sales, marketing and distribution company in ...
(Date:8/3/2015)... 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... the development of autologous cell therapies, announced today that RepliCel,s ... InvestMNT conference held in Minneapolis, Minnesota ... Hall,s presentation will highlight RepliCel,s 18-month milestones including CE Mark ... Europe , clinical data from both RCT-01 (tendon) and ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... market analysis and premium industry insights on the global resorcinol industry. The report ... collective study of vivid market scenarios and analysis of primary and secondary inputs ...
Breaking Biology Technology:Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4
... known as eosinophils have a central role in causing ... Hospital, Boston, has developed approaches to noninvasively visualize in ... mice with a disease that mimics asthma (experimental allergic ... developed to help assess the efficacy of treatments (both ...
... Ticket Software LLC as State,s,Fastest Growing Technology Company, ... Technology,Council and the accounting firm UHY LLP feted ... night at the Chevrolet Theater in,Wallingford. The list ... and included such well known brands as Priceline.com ...
... (Nasdaq: MEMY ) today announced that Michael Smith, ... a company update at,the Rodman & Renshaw Annual Global ... EST at the New York Palace Hotel, in New,York ... of the presentation by,visiting the "Investors" section of Memory ...
Cached Biology Technology:Connecticut Technology Council Honors UHY LLP Tech Top 40 Winners 2Connecticut Technology Council Honors UHY LLP Tech Top 40 Winners 3Connecticut Technology Council Honors UHY LLP Tech Top 40 Winners 4
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: